C

Corbus Pharmaceuticals

44 employees

Corbus Pharmaceuticals is a clinical-stage pharmaceutical company focused on treating inflammatory and fibrotic diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
systemic lupus erythematosus
Orphan diseases
Rare Diseases
Cystic Fibrosis
Scleroderma
Clinical Trials
Dermatomyositis
Systemic Sclerosis
Fibrosis
Inflammation
Lupus

Date founded

2014

Funding rounds raised

Total raised

$20M

from 4 investors over 4 rounds

C

Corbus Pharmaceuticals raised $15M on June 10, 2016

Investors: DAFNA Capital Management, LLC and Perceptive Advisors

C

Corbus Pharmaceuticals raised $20M on March 1, 2014

Investors: SternAegis Ventures

C

Corbus Pharmaceuticals raised undisclosed on January 1, 2010

Investors: Boston Harbor Angels Inc.

FAQ